SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Nuron Biotech Expands Portfolio With Exclusive, Worldwide License for an Amyloid Beta 42 DNA Vaccine Candidate for Alzheimer's Disease